Fisher & Paykel Healthcare
We visit Fisher & Paykel's East Tamaki campus and talk to Managing Director Lewis Gradon about his 41 year tenure, and how this iconic medical device business plans for the next 30 years.
Our conversation includes challenges like the tail from COVID-19, and being disciplined enough not to succumb to short-term share market pressure.
We also learn about the potential anesthesia market, where homecare is headed. Plus with most research and development locally based still, F&P hopes to stem the brain drain and act as a ‘brain magnet’ for young grads.
Brought to you by Sharesies, with BusinessDesk
Shared Lunch is hosted by BusinessDesk journalists including Frances Cook.
Each week, we’ll alternate between an interview with a company leader and an industry deep dive.
Tune in on YouTube to watch or subscribe to the podcast on Spotify, Google Podcasts, or Apple Podcasts.
Ok, now for the legal bit
Appearance on Shared Lunch is not an endorsement by Sharesies of the views of the presenters, guests, or the entities they represent. Their views are their own.
Shared Lunch is brought to you by Sharesies Australia Limited (ABN 94 648 811 830; AFSL 529893) in Australia and Sharesies Limited (NZ) in New Zealand. It is not financial advice. Information provided is general only and current at the time it’s provided, and does not take into account your circumstances, objectives, or needs. We do not provide recommendations and you should always read the disclosure documents available from the product's issuer before making a financial decision. Our disclosure documents and terms and conditions—including a Target Market Determination and IDPS Guide for Sharesies Australian customers—can be found on our relevant Australian or NZ website.
Investing involves risk. You might lose the money you start with. If you require financial advice, you should consider speaking with a qualified financial advisor.
Join over 700,000 investors
